Market cap
$8 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 13.82 | 1.98 | -28.12 | -53.76 | -62.43 |
| EBIT | 33.04 | 20.71 | -34.99 | -18.26 | -199.54 |
| Net Profit | 31.25 | 18.71 | -30.74 | 2.74 | -200.36 |
| EPS | 64.05 | 79.19 | 12.13 | 6.72 | -190.97 |
| Book Value | -- | -- | -68.54 | -48.15 | -26.29 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -3,104.19 | -1,859.97 | -6,727.57 | -7,793.22 | -959.90 |
| Net Margin
| -- | 2.00 | -6,523.04 | -- | -- |
| Return on equity
| -71.35 | -37.81 | -282.27 | -125.15 | -53.65 |
| Return on Capital
| -68.72 | -36.23 | -- | -119.74 | -51.75 |
| Return on Assets
| -61.76 | -32.73 | -130.78 | -105.69 | -47.25 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.06 | 0.04 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
-119.74
|
-51.75
|
-34.66
|
-11.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-282.27
Lower than Peers by 287.22
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-282.27
|
-125.15
|
-53.65
|
-35.24
|
-11.44
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-130.78
Lower than Peers by 133.24
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-130.78
|
-105.69
|
-47.25
|
-32.36
|
-10.06
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-6,727.57
Lower than Peers by 6,736.04
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-6,727.57
|
-7,793.22
|
-959.90
|
-559.46
|
-33.87
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-6,523.04
Lower than Peers by 6,527.72
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-6,523.04
|
-7,533.62
|
-961.37
|
-518.68
|
-33.62
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-28.12
Lower than Peers by 36.61
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-28.12
|
-0.84
|
-0.43
|
-0.80
|
-0.65
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-34.99
Lower than Peers by 45.64
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-34.99
|
-29.08
|
1.39
|
-228.79
|
-125.40
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
-30.74
Lower than Peers by 44.30
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-30.74
|
-24.59
|
-6.53
|
-148.15
|
-138.84
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
12.13
Lower than Peers by 8.37
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
12.13
|
-0.03
|
-0.01
|
-1.45
|
-1.38
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
-92.09
Lower than Peers by 99.09
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
-92.09
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
0.06
|
0.04
|
0.03
|
0.00
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.06
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
0.06
|
0.03
|
0.02
|
0.01
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.81
Lower than Peers by 1.01
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
1.81
|
3.87
|
4.41
|
10.81
|
23.94
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
1.52
Lower than Peers by 0.53
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
1.52
|
3.59
|
4.27
|
10.52
|
22.57
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
--
|
--
|
--
|
-0.78
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
7.28
Lower than Peers by 9.18
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
7.28
|
30.58
|
3.39
|
4.86
|
15.78
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.02
Lower than Peers by 0.48
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
0.02
|
0.01
|
0.05
|
0.06
|
0.24
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
94.75
|
21.62
|
153.62
|
140.44
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
1,695.96
|
500.36
|
304.39
|
243.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
4,247.85
|
873.05
|
106.23
|
51.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
-2,457.14
|
-351.07
|
351.77
|
332.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
0.00
|
-0.02
|
-0.04
|
-0.18
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
0.69
Lower than Peers by 3.10
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
0.69
|
0.01
|
0.02
|
0.02
|
0.02
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.52
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
0.52
|
0.22
|
0.74
|
1.47
|
7.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
8
Lower than Peers by 532
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Co-Diagnostics (CODX)
|
8
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|